BITPRISMIA
Canary Capital has filed an S-1 form with the SEC for the Canary Staked INJ ETF, a pioneering investment vehicle that combines exposure to Injective Protocol's INJ token with staking rewards, potentially reshaping crypto investment accessibility.
Injective Protocol has filed for an INJ Staked ETF, a development that could enhance accessibility to decentralized finance by combining the benefits of staking with the regulatory comfort of an ETF.